These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 831455)

  • 21. Cofactor of the "lupus anticoagulant".
    Rivard GE; Schiffman S; Rapaport SI
    Thromb Diath Haemorrh; 1974 Dec; 32(2-3):554-63. PubMed ID: 4141516
    [No Abstract]   [Full Text] [Related]  

  • 22. Laboratory diagnosis of congenital coagulation defects.
    Lowe GD; Forbes CD
    Clin Haematol; 1979 Feb; 8(1):79-94. PubMed ID: 310747
    [No Abstract]   [Full Text] [Related]  

  • 23. [Molecular-biology findings on various blood clotting factors].
    Fiedler H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1972; 98(2):121-39. PubMed ID: 4122840
    [No Abstract]   [Full Text] [Related]  

  • 24. Influence of glass and anticoagulant concentration on improvement of factor X deficiency tests.
    Honorato R; Ivanovic N; Novoa E
    Thromb Res; 1976 Jun; 8(6):769-75. PubMed ID: 960052
    [No Abstract]   [Full Text] [Related]  

  • 25. COAGULATION AND FIBRINOLYSIS IN INJURED PATIENTS.
    INNES D; SEVITT S
    J Clin Pathol; 1964 Jan; 17(1):1-13. PubMed ID: 14103515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prospective study of the potentiation of acenocoumarol by amiodarone.
    Richard C; Riou B; Berdeaux A; Fournier C; Khayat D; Rimailho A; Giudicelli JF; Auzépy P
    Eur J Clin Pharmacol; 1985; 28(6):625-9. PubMed ID: 4065185
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Control of anticoagulant therapy with coumarin derivatives. Evolution of the tests used and their standardization].
    Recalcati P; Perini A; Binda A
    Arch Sci Med (Torino); 1979; 136(3):369-84. PubMed ID: 398692
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A BLOOD CLOTTING DEFECT IN CHOLINE DEFICIENT RATS.
    WELLS IC
    Biochim Biophys Acta; 1964 May; 86():339-45. PubMed ID: 14171008
    [No Abstract]   [Full Text] [Related]  

  • 29. The relationship between Normotest and Thrombotest in patients on oral anticoagulant therapy.
    Refsum N; Arnesen H; Gilhuus-Moe CC; Godal HC
    Scand J Haematol; 1977 Apr; 18(4):333-6. PubMed ID: 854707
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Laboratory control of oral anticoagulation. Experiences from The Netherlands].
    Loeliger EA
    Schweiz Med Wochenschr; 1969 Aug; 99(35):1257-9. PubMed ID: 4900551
    [No Abstract]   [Full Text] [Related]  

  • 31. Studies on a family with combined functional deficiencies of vitamin K-dependent coagulation factors.
    Goldsmith GH; Pence RE; Ratnoff OD; Adelstein DJ; Furie B
    J Clin Invest; 1982 Jun; 69(6):1253-60. PubMed ID: 7085873
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The activation of coagulation by extracts of mucus: a possible pathway of intravascular coagulation accompanying adenocarcinomas.
    Pineo GF; Regoeczi E; Hatton MW; Brain MC
    J Lab Clin Med; 1973 Aug; 82(2):255-66. PubMed ID: 4352814
    [No Abstract]   [Full Text] [Related]  

  • 33. BLOOD COAGULATION. VII. COAGULATION II.
    DUGDALE M
    Memphis Mid South Med J; 1963 Jan; 38():19-22. PubMed ID: 14087826
    [No Abstract]   [Full Text] [Related]  

  • 34. Chromogenic substrate (S-2222) factor X assays in the follow-up of coumarin treated patients. No advantage over prothrombin time and/or thrombotest.
    Girolami A; Saggin L; Gazzetta R; Saltarin P
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(4):610-6. PubMed ID: 6170557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Classical factor X deficiency. Report of a further case.
    Girolami A; Coser P; Brunetti A; Prinoth O
    Acta Haematol; 1975; 53(2):118-27. PubMed ID: 804794
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanized amidolytic technique for determination of factor X and factor-X antigen, and its application to patients being treated with oral anticoagulants.
    van Wijk EM; Kahlé LH; ten Cate JW
    Clin Chem; 1980 Jun; 26(7):885-90. PubMed ID: 7379310
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coagulation profile and the ethanol gelation test with special reference to components consumed during coagulation.
    Slaastad RA; Godal HC
    Scand J Haematol; 1976 Jan; 16(1):25-32. PubMed ID: 1251137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The reaction of factor V in the serum under normal and pathological conditions].
    KAPPELER R
    Z Klin Med; 1955; 153(2):103-13. PubMed ID: 13248049
    [No Abstract]   [Full Text] [Related]  

  • 39. The predictability of bleeding by prothrombin times sensitive or insensitive to PIVKA during intensive oral anticoagulation.
    Arnesen H; Smith P
    Thromb Res; 1991 Feb; 61(3):311-4. PubMed ID: 1822957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Hemocoagulative response to K antivitaminics after 48 hours of treatment].
    Navarro Bort P; Llopis Guarner R; Giménez Lorente JV; Tormo Alfonso V
    Rev Clin Esp; 1974 Sep; 134(5):461-6. PubMed ID: 4438741
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.